Regeneration in Movement Disorders
31 – 40 of 144
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
[18F]RO948 tau positron emission tomography in genetic and sporadic frontotemporal dementia syndromes
- Contribution to journal › Article
-
Mark
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients
- Contribution to journal › Article
-
Mark
Performance of [18F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy
- Contribution to journal › Article
-
Mark
Real-world effectiveness of fremanezumab for the preventive treatment of migraine : Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
- Contribution to journal › Article
-
Mark
Identifying secreted biomarkers of dopaminergic ventral midbrain progenitor cells
- Contribution to journal › Article
-
Mark
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
- Contribution to journal › Article
-
Mark
A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies : which parameters better represent the efficacy?
- Contribution to journal › Article
-
Mark
Molecular Regulation of the Response of Brain Pericytes to Hypoxia
- Contribution to journal › Scientific review
-
Mark
The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases
- Contribution to journal › Article
-
Mark
Discriminative accuracy of the A/T/N scheme to identify cognitive impairment due to Alzheimer's disease
- Contribution to journal › Article
